For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Blog
Trump’s State of the Union: A closer look at the claims
Last night, President Trump delivered a State of the Union address filled with optimism, applause lines, and bold claims about the country’s direction. There…
Search Posts
Blog
Obama Administration Contributes to Life-Threatening Drug Shortages Even as it Decries Them
In a recent column, Michelle Malkin explained how Obamacare price controls, FDA and DEA rules, and Obama administration policies have contributed to shortages of…
Citation
Economics at Heart of Drug Shortages
Citation
Competitive Enterprise Institute Pleased With PDUFA Recommendations
Daily Caller
Regulation Is This Halloween’s Goblin
American entrepreneurs and small business owners have good reason to be scared this Halloween. According to a new Gallup poll, small business owners consider…
Blog
Biotechnology’s 29th Anniversary!
Twenty-nine years ago tomorrow, the U.S. Food and Drug Administration approved Eli Lilly’s and Genentech’s Humulin, making it the first ever fully…
Comment
CEI Comments to the Food and Drug Administration Regarding Medical Device Regulation
Full Document Available in PDF The Competitive Enterprise Institute appreciates the opportunity to submit these comments regarding…